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Although physical exercise strongly influences several laboratory parameters, data about the hematological changes after medium
distance running are scarce. We studied 31 middle-trained athletes (mean training regimen 217 ± 32min/week) who performed a
21.1 km, half-marathon run. Blood samples were collected before the run, at the end, and 3 and 20 hours thereafter. The complete
blood count was performed on Advia 2120 and included red blood cell (RBC), reticulocyte, and platelet counts; hemoglobin;
mean corpuscular volume (MCV); mean corpuscular hemoglobin (MCH); reticulocyte haemoglobin content (Ret CHR); RBC
distributionwidth (RDW),mean platelet volume (MPV). No significant variations were observed forMCHandRet CHR.TheRBC,
reticulocyte, and hemoglobin values modestly decreased after the run. The MCV significantly increased at the end of running but
returned to baseline 3 hours thereafter. The RDW constantly increased, reaching a peak 20 hours after the run. The platelet count
andMPVboth increased after the run and returned to baseline 3 hours thereafter.These resultsmay have implications for definition
of reference ranges and antidoping testing, and may also contribute to explaining the relationship between endurance exercise and
mortality, since previous studies reported that RDW and MPV may be significantly associated with cardiovascular disease.
1. Introduction
Physical exercise is an important preanalytical variable,
which strongly influences several biological and metabolic
pathways. These remarkable variations are often reflected by
concomitant changes of a number of laboratory parameters
[1]. The accurate identification of such paraphysiologic vari-
ations is pivotal in medicine and sports not only to prevent
misinterpretation of data and hence to define the real state
of health and fitness of the athletes but also to detect the
potential use of unfair doping practices and to assist sport
physicians in follow-up of athletic injuries [1].
Some previous studies have investigated the changes of
red blood cell (RBC) and platelet biology thatmay be induced
by endurance exercise [2–6], but the outcome of these trails
was often controversial due to the heterogeneity of study
populations (trained or untrained athletes), settings (sea level
or altitude), types of sport (sprint, endurance, or mixed), and
volumes and intensities of the physical effort (short, medium,
or long term performance). Among the various sports disci-
plines,mediumdistance running (i.e., from 10 to 21 km) is the
most practiced worldwide at both recreational or competitive
levels [7], since it provides a good balance between time spent
in running and job or personal life and does not require the
level of fitness and training of marathon or ultramarathon
running [8]. It has been reported, however, that the risk of
cardiac complications after medium and long distance run-
ning is not meaningless, with an overall incidence of cardiac
arrest of 0.37 and 0.19 per 100,000 runner hours in marathon
runners and half-marathon runners, respectively [9].
Data about the hematological changes after medium
distance running are scarce to the best of our knowledge.
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Even more importantly, the changes in RBC distribution
width (RDW) and mean platelet volume (MPV), which
are two emerging biomarkers of cardiovascular disease and
overall mortality [10, 11], are lacking. As such, we planned a
prospective study to assess the changes of some parameters of
the complete blood cell count (CBC) in athletes performing
moderate endurance exercise in order to establish whether
the increased cardiovascular problems that are occasionally
observed after this kind of exercise may be mirrored by
variation of either RDW or MPV.
2. Materials and Methods
The study population consisted in 31 middle-trained ath-
letes (11 females and 20 males; mean age 44 ± 7 years),
who performed a 21.1 km, half-marathon run. The athletes
were recruited from a team of nonprofessional, amateur
runners regularly involved in recreational running, with
mean training regimen of 217 ± 32min/week and max-
imal oxygen uptake of 51 ± 5mL/kg/min. No exclusion
criteria were applied. The distance was run on a hilly and
demanding route in the town of Verona, Italy (197m altitude
gap, with inclines averaging 1.8% and peaks up to 7%), in
a partially sunny day with temperatures between 14 and
17∘C and humidity between 60 and 80%. Blood samples
were collected in primary blood tubes containing K
2
EDTA
(Terumo Europe N.V., Leuven, Belgium) immediately before
the run and at the end of the trial, as well as 3 and 20
hours thereafter. All samples were immediately transported
to the clinical chemistry laboratory of the Academic Hospital
of Verona under controlled conditions of temperature and
humidity. The CBC was performed on Advia 2120 (Siemens
Healthcare Diagnostics, Tarrytown NY, USA) and included
RBC, reticulocyte, and platelet counts; hemoglobin; mean
corpuscular volume (MCV); mean corpuscular hemoglobin
(MCH); reticulocyte haemoglobin content (Ret CHR); RDW;
MPV. Results ofmeasurements were expressed asmedian and
interquartile range (IQR) and differences were analyzed with
Wilcoxon test for paired samples, using Analyse-it (Analyse-
it Software Ltd, Leeds, UK). All subjects gave an informed
consent for being enrolled in this study, which was approved
by the local academic ethical committee and performed in
accordance with the Helsinki Declaration of 1975.
3. Results
The results of this study are shown in Table 1. No significant
variations were observed for MCH and Ret CHR throughout
the study period. The number of RBC and the hemoglobin
values decreased significantly immediately after the run and
remained significantly decreased compared to the baseline
up to 20 hours thereafter. A similar trend was observed
for the absolute reticulocyte count. The MCV was found
to be significantly increased at the end of the run, but
values returned similar to the baseline 3 hours thereafter.
The RDW exhibited a remarkable trend towards increased
values, reaching the peak 20 hours after the end of the run
(median increase, 2.2%; IQR, 0.8–3.3%). Both the platelet
count and theMPV significantly increased after the end of the
run (median increase ofMPV, 5.7%; IQR, 0.6–9.3%), whereas
the values of both parameters returned to values similar to
the baseline 3 hours thereafter. The odds ratio (OR) for an
increased RDW value (i.e., >13.8%) was 3.7 (95% CI, 1.03–
13.4; 𝑃 = 0.044) 20 hours after the end of the run. Similarly,
the OR for an increased MPV value (i.e., >8.5 fL) was 10.4
(95% CI, 1.22–89.5; 𝑃 = 0.03) 3 hours after the end of the
half-marathon run.
4. Discussion
The results of this prospective study, which demonstrated
for the first time that both RDW and MPV values may sig-
nificantly vary in response to moderate endurance exercise,
may have at least three meaningful implications. The first
important issue is that the conventional reference ranges of
some parameters of the CBC, including those of the RDW
and MPV, may only be applicable in subjects at rest because
all the other parameters tested in this study exhibited sig-
nificant variations throughout the observational period. It is
noteworthy that although themaximumpercentage variation
of the RDW remained lower than the within-subject biologic
variation (i.e., 2.2% versus ±3.5%), the percentage increase of
MPV largely exceeded the within-subject biologic variation
(i.e., 5.7% versus ±4.3%) and should hence be considered
clinically significant [12]. Interestingly, we also observed that
the hemoglobin values marginally but significantly decreased
immediately after the run, and persisted significantly reduced
up to 20 hours thereafter. This is an original finding that was
not observed in a previous similar investigation [13] but has
minor clinical significance, since the maximum percentage
variation observed in our study (i.e., −3.2%) was very close to
the within-subject biologic variation (±3%) [12].
Another important issue is the potential impact of
these variations on antidoping testing. The athlete biological
passport (ABP) is a reliable strategy to monitor selected
biological variables over time that indirectly reveal the effects
of doping and includes a large number of hematological
variables [14]. More specifically, the so-called “adaptative
model” currently used by the World Anti-Doping Agency
(WADA) is based on an algorithm integrating hemoglobin,
RBC count, reticulocytes count, MCV, and MCH. According
to our data, all these variables except MCH were variably
modified by moderate endurance exercise, and this should
hence be clearly acknowledged when interpreting results of
both the hematological module and the abnormal blood
profile score (ABPS) [15].
Some conclusions can also be made about the impact of
a half-marathon run on the cardiovascular risk. Several lines
of evidence now attest that a high RDW is associated with
an increased risk of mortality and morbidity in patients with
heart disease [16], as well as in the general population [17, 18].
Similarly, an increased MPV conventionally reflects platelet
hyperreactivity [19], that is, a leading player in the complex
pathogenesis of cardiovascular disorders [20]. This aspect
has been confirmed in a recent meta-analysis showing that
elevated MPV is associated with acute myocardial infarction,
mortality following myocardial infarction, and restenosis
after coronary angioplasty [21].
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Table 1: Haematological changes in middle-trained athletes undergoing a half-marathon run.
Baseline Post run After 3 h After 20 h
RBC (1012/L) 4.9 (4.6–5.1) 4.8† (4.5–5.1) 4.6‡ (4.3–4.9) 4.7‡ (4.4–4.9)
Hemoglobin (g/L) 149 (145–155) 148† (140–155) 142‡ (136–148) 144‡ (139–150)
MCV (fL) 94.9 (91.9–96.3) 95.3† (93.5–97.3) 94.1 (92.3–95.8) 94.9 (91.5–97.1)
MCH (pg) 31.0 (30.0–31.1) 31.5 (30.0–32.0) 31.0 (30.3–32.8) 30.5 (30.0–32.0)
RDW (%) 13.3 (13.1–13.5) 13.4† (13.1–13.6) 13.4‡ (13.2–13.6) 13.5‡ (13.3–13.8)
Reticulocytes (109/L) 60.5 (49.5–72.5) 60.4 (49.6–74.2) 58.0‡ (46.7–69.3) 59.7‡ (46.9–65.9)
Ret CHR (pg) 31.0 (31.0–32.0) 31.0 (31.0–32.0) 31.0 (31.0–32.0) 31.0 (31.0–32.0)
Platelets (109/L) 255 (216–298) 311‡ (264–361) 263 (219–290) 255 (212–290)
MPV (fL) 9.2 (8.6–9.9) 9.5‡ (9.1–10.2) 9.1 (8.1–9.4) 9.2 (8.7–9.7)
†
𝑃 < 0.05 compared to baseline; ‡𝑃 < 0.01 compared to baseline.
MCH: mean corpuscular hemoglobin; MCV: mean corpuscular volume; MPV: mean platelet volume; RBC: red blood cell; RDW: RBC distribution width; Ret
CHR: reticulocyte hemoglobin concentration.
Although it has not been definitely elucidated whether
anisocytosis and a larger platelet volume are risk factors or
simple biomarkers of disease, the observation that RDW
and especially MPV consistently increase after a moder-
ate endurance effort reflects a clear perturbation of RBC
and platelet biology. This is noteworthy considering that,
according to recent statistics, the overall deaths per 100,000
marathon finishers were estimated at 0.75 (95% confidence
interval [CI], 0.38–1.13) and, evenmore interestingly,myocar-
dial infarction or atherosclerotic heart disease accounted for
the vastmajority of deaths (i.e.,>90%) [22].The results of this
study should hence represent a reliable basis to further define
whether anisocytosis and larger platelet volume may effec-
tively contribute to explanation of the relationship between
endurance exercise and mortality, especially in subjects at
higher risk of cardiovascular disease.
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CBC: Complete blood cell count
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